PEAK6 Investments’s Milestone Pharmaceuticals MIST Stock Holding History

PEAK6 Investments’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$919K	–	4906
2022 Q3	$919K	Buy	+100,000	New	+$758K	﹤0.01%	2291

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's MIST Position: Q1 2023 in Review

PEAK6 Investments sold out of Milestone Pharmaceuticals (MIST) in Q1 2023, closing a stake of 39,956 shares — an estimated $158K sold.

PEAK6 Investments first reported a position in MIST in Q4 2022 and held it in 1 quarter. The position peaked at $158K in Q4 2022. 50 funds tracked by Wall St. Rank hold MIST as of Q1 2023.

PEAK6 Investments reported no remaining Milestone Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
PEAK6 Investments sold 39,956 Milestone Pharmaceuticals shares in Q1 2023, an estimated $158K.
PEAK6 Investments first reported a position in Milestone Pharmaceuticals in Q4 2022 and held it in 1 quarter.
PEAK6 Investments's Milestone Pharmaceuticals position peaked at $158K in Q4 2022.
50 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.